New release of the IntelliFlowRx workflow management system provides significant operational enhancements and new capabilities
ENGLEWOOD, Colo., June 17 /PRNewswire/ -- Baxa Corporation announces the release of upgrades to its IntelliFlowRx workflow management system. IntelliFlowRx is designed to improve safety and accuracy in pharmacy-based IV admixture preparation. The system also streamlines compliance with sterile preparation regulatory steps while improving visibility to and oversight of IV room operations.
The latest upgrade adds a number of features to the IntelliFlowRx System, including the ability to define specific workflows for different types of doses within the health-system pharmacy, i.e., preparation modes and drug delivery routes - enabling customers to prepare oral liquid doses using IntelliFlowRx. In addition, the system can now manage "dose kitting" processes for pharmacies that assemble sets of doses and their specific ingredients outside of their IV room. The upgrade also provides audio alerts that inform pharmacy technicians of potential errors or discrepancies, which can improve production efficiency and reduce the opportunity for medication errors.
"This upgrade is a significant milestone in IntelliFlowRx's development," notes Dennis Schneider, Baxa Sr. VP of Marketing and Business Development. "The new features address requests from its growing customer base to extend the benefits of IntelliFlowRx into more areas of pharmacy operation."
In its first year of full production use, IntelliFlowRx has processed nearly a half million doses and serves more than 1,000 pharmacists and pharmacy technicians. Additional upgrades to the IntelliFlowRx Software are anticipated in the latter part of the year that will integrate the program with existing Baxa automation for more seamless management of health-system pharmacy workflow. IntelliFlowRx is manufactured by FHT, Inc. and distributed exclusively by Baxa Corporation. For more information on IntelliFlowRx, visit www.baxa.com/intelliflowRx.
About Baxa Corporation
Baxa, a customer-focused medical device company, provides innovative, solution-based technologies for medication handling and delivery. Its systems and devices promote the safe and efficient preparation, handling, packaging, and administration of medications. Key products include the PadLock(R) Set Saver, Rapid-Fill(TM) Automated Syringe Fillers, Exacta-Med(R) Oral Dispensers, MicroFuse(R) Syringe Infusers, Repeater(TM) Pharmacy Pumps, and Exacta-Mix(TM) and MicroMacro(TM) Multi-Source Automated Compounders; used worldwide in hospitals and healthcare facilities. Privately held, Baxa Corporation has subsidiaries and sales offices in Canada and the United Kingdom; direct representation in Austria, Belgium, Finland, France, Germany, Luxembourg, The Netherlands and Switzerland; and distribution partners worldwide. Further information is available at www.baxa.com.
Contact: Marian Robinson, Vice President, Marketing Baxa Corporation: 800.567.2292 ext. 2157 or 303.617.2157 Email: firstname.lastname@example.org Maggie Chamberlin Holben, APR Absolutely Public Relations: 303.984.9801 or 303.669.3558 Email: email@example.com
|SOURCE Baxa Corporation|
Copyright©2009 PR Newswire.
All rights reserved